Cargando…
Riluzole as a Neuroprotective Drug for Spinal Cord Injury: From Bench to Bedside
Spinal cord injury (SCI) is a devastating event resulting in permanent loss of neurological function. To date, effective therapies for SCI have not been established. With recent progress in neurobiology, however, there is hope that drug administration could improve outcomes after SCI. Riluzole is a...
Autores principales: | Nagoshi, Narihito, Nakashima, Hiroaki, Fehlings, Michael G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6272473/ https://www.ncbi.nlm.nih.gov/pubmed/25939067 http://dx.doi.org/10.3390/molecules20057775 |
Ejemplares similares
-
Longitudinal Impact of Acute Spinal Cord Injury on Clinical Pharmacokinetics of Riluzole, a Potential Neuroprotective Agent
por: Nguyen, Ashley, et al.
Publicado: (2021) -
Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial
por: Fehlings, M G, et al.
Publicado: (2016) -
Evaluation of the sodium-glutamate blocker riluzole in a preclinical model of ervical spinal cord injury
por: Wu, Yongchao, et al.
Publicado: (2010) -
Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in a Clinically Relevant Cervical Spinal Cord Injury Rat Model
por: Pieczonka, Katarzyna, et al.
Publicado: (2023) -
Spinal Cord Stimulation for Freezing of Gait: From Bench to Bedside
por: Fonoff, Erich Talamoni, et al.
Publicado: (2019)